Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma

Saved in:
Bibliographic Details
Published inHaemophilia : the official journal of the World Federation of Hemophilia Vol. 18; no. 1; pp. e34 - e35
Main Authors BIONDO, F., MATTURRO, A., SANTORO, C., LEPORACE, A., D'ELIA, G., BALDACCI, E., PIGNOLONI, P., PULSONI, A., FOÀ, R., MAZZUCCONI, M.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.01.2012
Subjects
Antibodies, Monoclonal, Murine-Derived - therapeutic use
Antineoplastic Agents - therapeutic use
Female
Humans
Induction Chemotherapy - methods
Lymphoma, B-Cell, Marginal Zone - complications
Lymphoma, B-Cell, Marginal Zone - drug therapy
Middle Aged
Rituximab
Stomach Neoplasms - complications
Stomach Neoplasms - drug therapy
von Willebrand Diseases - drug therapy
von Willebrand Diseases - etiology
von Willebrand Factor
Online AccessGet full text

Cover

More Information
Bibliography:ArticleID:HAE2681
istex:F8D806DE6F1EE6C247283D4DF3C3D558CB69754B
ark:/67375/WNG-C6S8DX53-6
ISSN:1351-8216
1365-2516
DOI:10.1111/j.1365-2516.2011.02681.x